Prognozy (mln) dla Dermapharm Holding SE
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
1,187.83 |
1,193.54 |
1,243.31 |
1,272.29 |
1,328.43 |
1,369.00 |
Przychód Δ r/r |
0.00% |
0.48% |
4.17% |
2.33% |
4.41% |
3.05% |
Przychód (min) |
1,145.37 |
1,174.20 |
1,225.00 |
1,272.29 |
1,307.90 |
1,347.84 |
Przychód (max) |
1,205.04 |
1,212.57 |
1,255.24 |
1,272.29 |
1,345.31 |
1,386.40 |
EBITDA (średnia) |
339.00 |
344.29 |
358.65 |
367.01 |
383.20 |
394.91 |
EBIT (średnia) |
247.72 |
251.58 |
262.07 |
268.18 |
280.01 |
288.57 |
EBIT % |
20.85% |
21.08% |
21.08% |
21.08% |
21.08% |
21.08% |
Zysk netto (średni) |
109.40 |
124.23 |
138.84 |
152.70 |
182.21 |
0.00 |
Zysk netto % |
9.21% |
10.41% |
11.17% |
12.00% |
13.72% |
0.00% |
EPS (średnia) |
2.04 |
2.31 |
2.56 |
2.83 |
3.38 |
0.00 |
Liczba analityków (Przychody) |
4 |
5 |
5 |
5 |
1 |
2 |
Liczba analityków (EPS) |
4 |
5 |
5 |
5 |
2 |
1 |
symbol |
DMP.DE |
DMP.DE |
DMP.DE |
DMP.DE |
DMP.DE |
DMP.DE |